43192-34-3

Basic information

• Product Name: 4-BROMO-3-METHOXYBENZALDEHYDE
• Synonyms: 4-BROMO-3-METHOXYBENZALDEHYDE;3-Methoxy-4-bromobenzaldehyde;Benzaldehyde, 4-bromo-3-methoxy-
• CAS NO: 43192-34-3
• Molecular Formula: C₈H₇BrO₂
• Molecular Weight: 215.045
• Mol File: 43192-34-3.mol
• Article Data: 17

Chemical Properties

• Melting Point: 126-127℃ (dichloromethane )
• Boiling Point: 289.7±25.0 °C at 760 mmHg
• Flash Point: 129.0±23.2 °C
• Appearance: /
• Density: 1.5±0.1 g/cm3
• Vapor Pressure: 0.0±0.6 mmHg at 25°C
• Refractive Index: 1.585
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 4-BROMO-3-METHOXYBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-METHOXYBENZALDEHYDE(43192-34-3)
• EPA Substance Registry System: 4-BROMO-3-METHOXYBENZALDEHYDE(43192-34-3)

Safety Data

• Hazardous Substances Data: 43192-34-3(Hazardous Substances Data)

Usage

General Description

4-Bromo-3-methoxybenzaldehyde is a chemical compound with the molecular formula C8H7BrO2. It is known for its aromatic and aldehydic properties, and is commonly used in the synthesis of various organic compounds. This chemical is a pale yellow solid with a strong, sweet, and floral odor. It is often used as a building block in the production of pharmaceuticals, agrochemicals, and other fine chemicals. Additionally, 4-Bromo-3-methoxybenzaldehyde is also utilized in the manufacturing of dyes and fragrances. Its unique structure and reactivity make it a valuable intermediate in organic synthesis, and its diverse applications make it an important compound in the chemical industry.

InChI:InChI=1S/C8H7BrO2/c1-11-8-4-6(5-10)2-3-7(8)9/h2-5H,1H3

Upstream product

• 6971-51-3 3-methoxybenzyl alcohol 
• 591-31-1 3-methoxy-benzaldehyde 
• 17100-63-9 methyl 4-bromo-3-methoxybenzoate 
• 19056-40-7 4-bromo-3-methoxyaniline 
• 704-13-2 5-formyl-2-nitrophenol 
• 80410-57-7 3-methoxy-4-nitrobenzaldehyde 
• 120315-65-3 4-bromo-3-methoxy-benzonitrile 
• 1148110-16-0 1-bromo-4-(bromomethyl)-2-methoxybenzene 
• 90151-40-9 4-amino-3-methoxybenzaldehyde 
• 932372-99-1 2-bromo-5-iodophenol 
• 755027-18-0 1-bromo-4-iodo-2-methoxybenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 77-78-1 dimethyl sulfate 
• 20035-32-9 4-bromo-3-hydroxy-benzaldehyde 

Downstream Products

• 132040-97-2 1-Bromo-4-dimethoxymethyl-2-methoxy-benzene 
• 1330753-51-9 1-(3-methoxy-4-bromophenyl)-7-(3-hydroxy-4-methoxyphenyl)heptan-3-one 
• 113081-51-9 2-(4-bromo-3-methoxy-phenyl)-ethylamine 
• 1428796-73-9 N-(4-bromo-3-methoxyphenethyl)acetamide 
• 1428796-07-9 (R)-3-(3-fluorophenyl)-N-(1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-8-methoxy-9-(pyridin-3-yl)-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxamide 
• 1428796-81-9 ethyl 9-ethyl-3-(3-fluorophenyl)-8-methoxy-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylate 
• 1428796-82-0 9-ethyl-3-(3-fluorophenyl)-8-methoxy-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylic acid 
• 1428796-08-0 (R)-9-ethyl-3-(3-fluorophenyl)-N-(1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-8-methoxy-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxamide 
• 1428796-84-2 ethyl 3-(3-fluorophenyl)-8-methoxy-9-(morpholine-4-carbonyl)-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylate 
• 1428796-85-3 3-(3-fluorophenyl)-8-methoxy-9-(morpholine-4-carbonyl)-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxylic acid 
• 1428796-12-6 (R)-3-(3-fluorophenyl)-N-(1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-8-methoxy-9-(morpholine-4-carbonyl)-5,6-dihydropyrrolo[2,1-a]isoquinoline-2-carboxamide 
• 1289126-21-1 4-ethyl-3-methoxy-benzaldehyde 

Relevant articles and documents

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

The present invention provides a compound of formula (Ia) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, solid forms, combinations of pharmacologically active agents, pharmaceutical compositions and methods of using such compounds and solid forms thereof to treat or prevent parasitic diseases, for example malaria.

TYK2 INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

PHARMACEUTICAL COMPOUNDS

This invention relates to compounds that inhibit or modulate the activity of Chk-1 kinase. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds.